Sökning: onr:"swepub:oai:prod.swepub.kib.ki.se:145774398" >
Modulation of IL-6/...
Modulation of IL-6/STAT3 signaling axis in CD4+FOXP3- T cells represents a potential antitumor mechanism of azacitidine
-
Lamprianidou, E (författare)
-
Kordella, C (författare)
-
Kazachenka, A (författare)
-
visa fler...
-
Zoulia, E (författare)
-
Bernard, E (författare)
-
Filia, A (författare)
-
Laidou, S (författare)
-
Garantziotis, P (författare)
-
Vassilakopoulos, TP (författare)
-
Papageorgiou, SG (författare)
-
Pappa, V (författare)
-
Galanopoulos, AG (författare)
-
Viniou, N (författare)
-
Nakou, E (författare)
-
Kalafati, L (författare)
-
- Chatzidimitriou, A (författare)
- Karolinska Institutet
-
Kassiotis, G (författare)
-
Papaemmanuil, E (författare)
-
Mitroulis, I (författare)
-
Kotsianidis, I (författare)
-
visa färre...
-
(creator_code:org_t)
- 2021-01-06
- 2021
- Engelska.
-
Ingår i: Blood advances. - : American Society of Hematology. - 2473-9537 .- 2473-9529. ; 5:1, s. 129-142
- Relaterad länk:
-
https://ashpublicati...
-
visa fler...
-
http://kipublication...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- CD4+ T cells orchestrate immune responses and are actively engaged in shaping tumor immunity. Signal transducer and activator of transcription (STAT) signaling controls the epigenetic tuning of CD4+ T-cell differentiation and polarization, and perturbed STAT signaling networks in CD4+ T cells subvert antitumor immunity in malignancies. Azacitidine (AZA), the mainstay therapy for high-risk myelodysplastic syndromes (HR-MDS), affects CD4+ T-cell polarization and function, but whether this contributes to AZA efficacy is currently unknown. By using functional proteomic, transcriptomic, and mutational analyses in 73 HR-MDS patients undergoing AZA therapy, we demonstrate that responding patients exhibited a coordinated CD4+ T-cell immune response and downregulated the inflammatory cytokine signaling pathways in CD4+ T cells after AZA, in contrast to nonresponders who upregulated the same pathways. We further observed an AZA-mediated downregulation of intereukin-6 (IL-6)—induced STAT3 phosphorylation in CD4+FOXP3− conventional T cells (Tcons) that correlated independently with better response and survival, whereas it was also not associated with the mutation number and profile of the patients. The AZA-induced downregulation of IL-6/STAT3 axis in Tcons restored the STAT signaling architecture in CD4+ T-cell subsets, whereas STAT signaling networks remained disorganized in patients who upregulated IL-6/STAT3 activity in Tcons. Given the pivotal role of CD4+ T cells in adaptive immunity, our findings suggest that the downregulation of the IL-6/STAT3 pathway in Tcons potentially constitutes a previously unrecognized immune-mediated mechanism of action of AZA and sets the scene for developing rational strategies of AZA combinations with IL-6/STAT3 axis inhibitors.
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Lamprianidou, E
-
Kordella, C
-
Kazachenka, A
-
Zoulia, E
-
Bernard, E
-
Filia, A
-
visa fler...
-
Laidou, S
-
Garantziotis, P
-
Vassilakopoulos, ...
-
Papageorgiou, SG
-
Pappa, V
-
Galanopoulos, AG
-
Viniou, N
-
Nakou, E
-
Kalafati, L
-
Chatzidimitriou, ...
-
Kassiotis, G
-
Papaemmanuil, E
-
Mitroulis, I
-
Kotsianidis, I
-
visa färre...
- Artiklar i publikationen
-
Blood advances
- Av lärosätet
-
Karolinska Institutet